Ferritin‐Hijacking Nanoparticles Spatiotemporally Directing Endogenous Ferroptosis for Synergistic Anticancer Therapy
Source abstract
Abstract
Abstract Existing ferroptosis as an iron‐dependent form of regulated cell death primarily relies on importing exogenous iron. However, the excessive employment of toxic materials may cause potential adverse effects on human health. Herein, a ferritin‐hijacking nanoparticle (Ce6‐PEG‐HKN15) is fabricated, by conjugating the ferritin‐homing peptide HKN15 with the photosensitizer chlorin e6 (Ce6) for endogenous ferroptosis without introducing Fenton‐reactive metals. Once internalized, the designed Ce6‐PEG‐HKN15 NPs can specifically accumulate around ferritin. With laser irradiation, the activated Ce6 in nanoparticles potently generates reactive oxygen species (ROS) surrounding ferritin. Abundant ROS not only helps to destroy the iron storage protein and activate endogenous ferroptosis but also directly kill tumor cells. In turn, the released iron partially interacts with intracellular excess H2O2 to produce O2, thereby enhancing photodynamic therapy and further amplifying oxidative stress. Overall, this work highlights the possibility of endogenous ferroptosis via spatiotemporally destroying ferritin, offering a paradigm for synergistic ferroptosis–photodynamic antitumor therapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Pharmaceutics College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 P. R. China
Shulan International Medical College Zhejiang Shuren University Hangzhou 310015 P. R. China
Department of Radiology Lishui Hospital of Zhejiang University Lishui 323000 P. R. China
Funding
Natural Science Foundation of Zhejiang Province
References (53)
Show source-provided references
1. 10.1016/j.freeradbiomed.2018.04.03410.1016/j.freeradbiomed.2018.04.034 ↗
2. 10.1038/s41571-020-00462-010.1038/s41571-020-00462-0 ↗
3. 10.1002/adma.20210422310.1002/adma.202104223 ↗
4. 10.1002/smll.20210386810.1002/smll.202103868 ↗
5. 10.1038/s41392-020-00216-510.1038/s41392-020-00216-5 ↗
6. 10.1002/advs.20180198610.1002/advs.201801986 ↗
7. 10.1021/acsnano.8b0620110.1021/acsnano.8b06201 ↗
8. 10.1021/acsami.1c1103210.1021/acsami.1c11032 ↗
9. 10.1002/adma.20170400710.1002/adma.201704007 ↗
10. 10.1021/jacs.0c0560410.1021/jacs.0c05604 ↗
11. 10.1002/anie.20151003110.1002/anie.201510031 ↗
12. 10.1016/j.semcancer.2021.04.00110.1016/j.semcancer.2021.04.001 ↗
13. 10.1016/j.mam.2020.10086010.1016/j.mam.2020.100860 ↗
14. 10.1038/s41565-019-0419-910.1038/s41565-019-0419-9 ↗
15. Luo L. · Am. J. Cancer Res. · 2021 · 11 · 5508
16. 10.1016/0003-9861(74)90209-410.1016/0003-9861(74)90209-4 ↗
17. 10.1007/BF0180630710.1007/BF01806307 ↗
18. 10.1007/s10549-012-2405-x10.1007/s10549-012-2405-x ↗
19. 10.1080/15548627.2019.168798510.1080/15548627.2019.1687985 ↗
20. 10.1093/mtomcs/mfab02110.1093/mtomcs/mfab021 ↗
21. 10.1088/0957-4484/27/17/17570110.1088/0957-4484/27/17/175701 ↗
22. 10.1080/15548627.2016.118736610.1080/15548627.2016.1187366 ↗
23. 10.1016/j.freeradbiomed.2020.08.00910.1016/j.freeradbiomed.2020.08.009 ↗
24. 10.1371/journal.pone.004003010.1371/journal.pone.0040030 ↗
25. 10.1073/pnas.081201010610.1073/pnas.0812010106 ↗
26. 10.1002/pro.248610.1002/pro.2486 ↗
27. 10.1038/nrmicro.2017.2610.1038/nrmicro.2017.26 ↗
28. 10.1007/s00204-022-03225-110.1007/s00204-022-03225-1 ↗
29. 10.1016/j.scitotenv.2020.13922910.1016/j.scitotenv.2020.139229 ↗
30. 10.1038/s41571-020-0410-210.1038/s41571-020-0410-2 ↗
31. 10.1002/anie.20211292510.1002/anie.202112925 ↗
32. 10.1002/adma.20200689210.1002/adma.202006892 ↗
33. 10.1016/j.ajps.2021.05.00110.1016/j.ajps.2021.05.001 ↗
34. 10.7150/thno.3286710.7150/thno.32867 ↗
35. 10.1016/j.trecan.2021.01.01310.1016/j.trecan.2021.01.013 ↗
36. 10.1038/s41568-022-00459-010.1038/s41568-022-00459-0 ↗
37. 10.1186/s12951-021-00952-y10.1186/s12951-021-00952-y ↗
38. 10.1039/D0NR08757B10.1039/D0NR08757B ↗
39. 10.1002/adma.20190151310.1002/adma.201901513 ↗
40. 10.1021/bc100116v10.1021/bc100116v ↗
41. 10.3390/ijms2213702310.3390/ijms22137023 ↗
42. 10.1021/acs.biomac.0c0156210.1021/acs.biomac.0c01562 ↗
43. 10.1182/blood.V99.10.350510.1182/blood.V99.10.3505 ↗
44. 10.1093/jnci/55.4.79110.1093/jnci/55.4.791 ↗
45. 10.1159/00047503710.1159/000475037 ↗
46. 10.1242/jcs.107.12.346110.1242/jcs.107.12.3461 ↗
47. 10.1083/jcb.127.5.121710.1083/jcb.127.5.1217 ↗
48. 10.1083/jcb.20090808620100331c10.1083/jcb.20090808620100331c ↗
49. 10.1002/advs.20190262110.1002/advs.201902621 ↗
50. 10.1038/3507453910.1038/35074539 ↗
51. 10.1016/S0168-8278(01)00222-710.1016/S0168-8278(01)00222-7 ↗
52. 10.1016/j.biomaterials.2020.11991110.1016/j.biomaterials.2020.119911 ↗
53. 10.1021/acsnano.7b0773710.1021/acsnano.7b07737 ↗